PTC Therapeutics: Q1 Earnings Snapshot

Published: 2026-05-07 17:01:49 ET PTCT

Published on 05/07/2026 at 05:01 pm EDT

WARREN, N.J. (AP) — WARREN, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $2.8 million in its first quarter.

On a per-share basis, the Warren, New Jersey-based company said it had a loss of 3 cents.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.

The biopharmaceutical company posted revenue of $272.6 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $233.7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News